Vivozon Pharmaceutical Co., Ltd.

KOSDAQ:A082800 Stock Report

Market Cap: ₩399.5b

Vivozon Pharmaceutical Dividends and Buybacks

Dividend criteria checks 0/6

Vivozon Pharmaceutical does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.005%

Buyback Yield

Total Shareholder Yield0.005%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 40% But Its Business Is Yet to Catch Up

Dec 12
Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 40% But Its Business Is Yet to Catch Up

We Think Vivozon Pharmaceutical (KOSDAQ:082800) Is Taking Some Risk With Its Debt

Dec 02
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Is Taking Some Risk With Its Debt

Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 35% But Its Business Is Yet to Catch Up

Oct 28
Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 35% But Its Business Is Yet to Catch Up

What Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) 33% Share Price Gain Is Not Telling You

Aug 02
What Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) 33% Share Price Gain Is Not Telling You

Vivozon Pharmaceutical (KOSDAQ:082800) Has A Somewhat Strained Balance Sheet

Jul 29
Vivozon Pharmaceutical (KOSDAQ:082800) Has A Somewhat Strained Balance Sheet

Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

Jun 04
Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Mar 23
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

May 06
Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Feb 18
Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Dec 04
Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A082800's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A082800's dividend payments have been increasing.

Dividend Yield vs Market

Vivozon Pharmaceutical Dividend Yield vs Market
How does A082800 dividend yield compare to the market?
SegmentDividend Yield
Company (A082800)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Semiconductor)0.7%
Analyst forecast (A082800) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A082800's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A082800's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A082800's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A082800 has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 01:18
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivozon Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mok Hyun JiMERITZ Securities Co., Ltd.
Hyun Yong KimSK Securities Co., Ltd.